Gallagher J E, Shank T, Lewtas J, Lefevre P A, Ashby J
U.S. EPA, Genetic Toxicology Division, Health Effects Research Laboratory, Research Triangle Park, NC.
Mutat Res. 1991 Jun;252(3):247-57. doi: 10.1016/0165-1161(91)90004-r.
Groups of male Alderley Park rats were dosed concomitantly with 2-acetylaminofluorene (2AAF) by gavage at doses between 0.01 mg/kg and 40 mg/kg, and livers sampled 2-72 h later. The liver of one group of animals was perfused to yield hepatocytes which were assayed in vitro for unscheduled DNA synthesis (UDS) via incorporation of tritiated thymidine and autoradiography. DNA was extracted from the livers of the other group and DNA adduct levels determined using the 32P-postlabelling technique. The major C-8 2-aminofluorene/guanosine adduct and 3 minor adducts were quantitated, enabling the relative sensitivity of the 2 techniques to be compared. A dose- and time-related UDS response was observed, which, at the most sensitive time-point (12 h) enabled DNA repair to be discerned at a dose level of 0.1-1 mg/kg of 2AAF, a response classified as formally positive at 5 mg/kg 2AAF. Only the C-8 adduct, as determined by 32P-postlabelling, was discernible at 0.01 mg/kg of 2AAF, although other adducts were visible on autoradiograms at higher dose levels. It is concluded that as part of a well-defined dose response, UDS can be discerned with confidence for doses of 2AAF between approximately 0.1 and 5 mg/kg, and DNA adducts for doses of 2AAF between approximately 0.01 and 1 mg/kg. Discernible UDS for 2AAF in the rat liver is apparent at approximately 13 DNA (total) adducts/10(8) nucleotides, or approximately 8 DNA (C-8) adducts/10(8) nucleotides. The presumed C-8 2-acetylaminofluorene/guanosine adduct, prepared by reaction of 2-acetoxy-2-acetylaminofluorene (2AAAF) with DNA, was a significant but unreliable marker of 2AAF/DNA adducts in the rat liver in vivo. DNA repair did not appear to remove DNA adducts selectively, and adducts remained in DNA when discernible DNA repair had ceased.
将雄性奥尔德利公园大鼠分组,通过灌胃同时给予剂量在0.01mg/kg至40mg/kg之间的2-乙酰氨基芴(2AAF),并在2至72小时后采集肝脏样本。对一组动物的肝脏进行灌注以获取肝细胞,通过掺入氚标记的胸腺嘧啶核苷和放射自显影术在体外检测其非程序性DNA合成(UDS)。从另一组动物的肝脏中提取DNA,并使用32P后标记技术测定DNA加合物水平。对主要的C-8 2-氨基芴/鸟苷加合物和3种次要加合物进行定量,从而能够比较这两种技术的相对灵敏度。观察到与剂量和时间相关的UDS反应,在最敏感的时间点(12小时),在2AAF剂量为0.1至1mg/kg时能够识别DNA修复,在2AAF剂量为5mg/kg时该反应被分类为正式阳性。通过32P后标记测定,仅在2AAF剂量为0.01mg/kg时可识别C-8加合物,尽管在更高剂量水平的放射自显影片上可见其他加合物。结论是,作为明确剂量反应的一部分,对于2AAF剂量在约0.1至5mg/kg之间,能够可靠地识别UDS,对于2AAF剂量在约0.01至1mg/kg之间,能够识别DNA加合物。在大鼠肝脏中,当约13个DNA(总)加合物/10^8个核苷酸或约8个DNA(C-8)加合物/10^8个核苷酸时,2AAF的可识别UDS明显。通过2-乙酰氧基-2-乙酰氨基芴(2AAAF)与DNA反应制备的推测的C-8 2-乙酰氨基芴/鸟苷加合物,是大鼠肝脏体内2AAF/DNA加合物的一个重要但不可靠的标志物。DNA修复似乎没有选择性地去除DNA加合物,并且当可识别的DNA修复停止时,加合物仍保留在DNA中。